{"id":"W2767911405","doi":"10.1155/2017/5264216","title":"Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn’s Disease","year":2017,"lang":"en","type":"article","venue":"Case Reports in Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Saskatchewan","funders":"","keywords":"Vedolizumab; Ustekinumab; Medicine; Refractory (planetary science); Crohn's disease; Internal medicine; Maintenance therapy; Disease; Gastroenterology; Adalimumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003465112,0.0001336956,0.0001800086,0.00004447555,0.00008105109,0.000009481736,0.00006203533,0.00006696388,0.0000185491],"category_scores_gemma":[0.0002971514,0.00007698865,0.00003957743,0.0000223664,0.000393833,0.000003574162,0.00002765991,0.00004142019,2.326335e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001994267,"about_ca_system_score_gemma":0.00007672447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001290989,"about_ca_topic_score_gemma":0.0002315652,"domain_scores_codex":[0.9990945,0.00008557997,0.0003083421,0.0002678955,0.00009684892,0.0001468042],"domain_scores_gemma":[0.9988214,0.00001798789,0.0002100394,0.0008416043,0.00003272957,0.0000762478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"observational","study_design_scores_codex":[0.0009125401,0.0003687699,0.3261617,0.00004098089,0.00003616861,0.6522115,0.0008459223,0.000008683225,0.004742216,0.00003760307,0.0001906303,0.01444336],"study_design_scores_gemma":[0.001978144,0.0004835917,0.9880745,0.00004428284,0.00002442373,0.005346869,0.0003283813,0.0000149455,0.0005017238,0.0001797152,0.002917722,0.000105728],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960114,0.002834422,0.000002557893,0.0002401426,0.0001314201,0.0003863657,0.000005961687,0.000002716442,0.0003849998],"genre_scores_gemma":[0.9978644,0.001676753,0.00001084321,0.0000995536,0.0001856137,0.00005930642,0.00002858795,0.000008290279,0.00006667885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6619128,"threshold_uncertainty_score":0.3139506,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02769528129728425,"score_gpt":0.312810326434479,"score_spread":0.2851150451371947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}